Mr. Bernard Tourillon reports

HPQ SILICON CLOSED OVER $1.0 MILLION NON-BROKERED PRIVATE PLACEMENT

HPQ Silicon Inc. has closed a non-brokered private placement of 6,170,442 common shares at a price of 16.25 cents per share, for gross proceeds of $1,002,696.83.

All securities issued under the private placement are subject to a statutory hold period of four months and one day from the closing date of the placement, in accordance with applicable Canadian securities laws. The placement remains subject to final acceptance by the TSX Venture Exchange.

In connection with the private placement, HPQ will pay commissions by issuing 333,303 warrants to CI Investment Services Inc. Each warrant entitles the agent to purchase one common share at an exercise price of 18 cents per share for a period of 48 months from the closing date of the placement, subject to the same four-month-and-one-day hold period.

Use of proceeds

In addition to general working capital and corporate purposes, the net proceeds from the financing will be strategically deployed to advance HPQ's commercialization initiatives across its three core technology pillars:

• Fumed silica reactor (FSR): focus on client-driven commercial scale-up opportunities and revenue generations pathways;
• HPQ Endura+: commercialization of HPQ Endura+ cells and advancement of the NRCan-supported silicon-based anode material program;
• Metagene: continue technology development and commercialization of the autonomous green hydrogen production platform.

Management participation

As part of the financing, Bernard Tourillon, chairman, president, chief executive officer and director, and insider and related party of HPQ, directly or through entities under his control, subscribed for 615,384 common shares ($99,999.90). Following the closing of the private placement, Mr. Tourillon beneficially owns or controls, directly or indirectly, 22,796,794 common shares, representing approximately 5.29 per cent of the company's issued and outstanding shares.

Mr. Tourillon's participation constitutes a related party transaction under Multilateral Instrument 61-101 and TSX Venture Exchange Policy 5.9. The company relied on applicable exemptions from formal valuation and minority shareholder approval requirements, as the fair market value of the insider participation did not exceed 25 per cent of the company's market capitalization. The board of directors approved the private placement, including insider participation.

"My $100,000 investment reflects my conviction in the company's ability to deliver on its near-term execution priorities and my continued confidence in HPQ's strategy and long-term value creation," said Mr. Tourillon. "With multiple technology platforms now transitioning from development to commercial readiness, these funds allow us to maintain momentum, advance near-term milestones and remain disciplined as we move toward revenue-generating activities.

About HPQ Silicon Inc.

HPQ Silicon is a Quebec-based TSX Venture Exchange industrial issuer focused on innovation in advanced materials and critical process development. In partnership with its research and development partner Novacium, of which HPQ is a shareholder, the company is advancing next-generation silicon-based anode materials (Gen3) for batteries, commercializing its Endura+ lithium-ion cells, and developing breakthrough clean-hydrogen and waste-to-energy technologies, for which HPQ holds exclusive North American rights. HPQ is also pursuing proprietary technologies to become a low-cost, zero-CO2 (carbon dioxide) producer of fumed silica and high-purity silicon, with technical support from PyroGenesis Inc. Together, these initiatives position HPQ to capture growth opportunities in the energy storage, clean hydrogen and advanced materials markets essential to achieving global net-zero goals.

We seek Safe Harbor.